A detailed history of Usa Financial Portformulas Corp transactions in Amgen Inc stock. As of the latest transaction made, Usa Financial Portformulas Corp holds 4,131 shares of AMGN stock, worth $1.09 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
4,131
Holding current value
$1.09 Million
% of portfolio
0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $1.28 Million - $1.39 Million
4,131 New
4,131 $1.33 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $855,006 - $1.03 Million
3,180 New
3,180 $904,000
Q1 2023

Nov 27, 2023

SELL
$225.79 - $275.2 $3,386 - $4,128
-15 Reduced 71.43%
6 $1,000
Q3 2022

Oct 24, 2022

BUY
$224.46 - $253.15 $4,713 - $5,316
21 New
21 $5,000
Q1 2022

Aug 16, 2022

SELL
$219.27 - $242.57 $3,289 - $3,638
-15 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $15,313 - $17,525
-77 Reduced 83.7%
15 $3,000
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $19,528 - $22,880
92 New
92 $20,000
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $2,441 - $2,844
-11 Closed
0 $0
Q4 2020

Jan 29, 2021

SELL
$216.38 - $257.67 $2.52 Million - $3 Million
-11,654 Reduced 99.91%
11 $3,000
Q3 2020

Oct 09, 2020

BUY
$234.65 - $260.95 $2.74 Million - $3.04 Million
11,665 New
11,665 $2.97 Million
Q1 2020

Apr 13, 2020

SELL
$182.24 - $241.7 $1,640 - $2,175
-9 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $1,702 - $2,188
9 New
9 $2,000
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $4.91 Million - $5.53 Million
-27,134 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $4.84 Million - $5.65 Million
27,134 New
27,134 $5.63 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.